Insights

Nathaniel Lipkus Nathaniel Lipkus

Type (0)

Results

All Insights

Video September 15, 2025

Can AI be an inventor on a patent or author of a copyrighted work?

Artificial intelligence (AI) proponents are testing the limits of today’s intellectual property laws. AI technologies, such as ChatGPT and DALL-E,...

Read more
Can AI be an inventor on a patent or author of a copyrighted work?
Osler Update April 17, 2025

Avoiding IP quicksand: lessons from ITP SA v. CNOOC Petroleum North America ULC

The decision serves as a reminder of the potential consequences of failing to manage IP diligently within large infrastructure projects.

Read more
Avoiding IP quicksand: lessons from ITP SA v. CNOOC Petroleum North America ULC
Report December 5, 2024

The impact of stronger drug dosing patents on Canadian drug access

A consistent pain point and focus of reform within the system is the high cost of prescription drugs.

Read more
The impact of stronger drug dosing patents on Canadian drug access
Osler Update September 16, 2024

Curb your (lobbying) enthusiasm? Navigating Canada’s lobbying regulations – insights for the pharmaceutical industry

The interplay of legal frameworks, ethical considerations and diverse stakeholders make lobbying a complex and sensitive process.

Read more
Curb your (lobbying) enthusiasm? Navigating Canada’s lobbying regulations – insights for the pharmaceutical industry
Osler Update July 31, 2024

Winning wellness: strategic IP and regulatory considerations in Canada’s booming natural health products industry

Canadian natural health products have surged to an industry worth more than $13 billion in recent years. A strategic approach to intellectual...

Read more
Winning wellness: strategic IP and regulatory considerations in Canada’s booming natural health products industry
Osler Update July 22, 2024

U.K. appellate court rules artificial neural network application is not patent-eligible subject matter

Although artificial neural networks (ANNs) have evolved to increasingly form the backbone of modern commerce, their patentability remained...

Read more
U.K. appellate court rules artificial neural network application is not patent-eligible subject matter
Osler Update November 10, 2022

PMPRB releases long-awaited draft guidelines regarding excessive drug pricing under new regime

The Patented Medicine Prices Review Board (PMPRB) has updated its approach to excessive pricing. Osler’s Nathaniel Lipkus and Yael Mansour discuss...

Read more
PMPRB releases long-awaited draft guidelines regarding excessive drug pricing under new regime
Osler Update August 17, 2022

Patty patents: Canadian courtroom grilling in the works?

There is a new beef in the plant-based meat market, but you won’t find this one on the shelves of your local grocery store.

Read more
Osler Update June 22, 2022

Canadian Court again rejects problem-solution approach to subject-matter eligibility of computer-implemented patents

The Federal Court of Canada has once again rejected the problem-solution approach to determining eligibility for computer-implemented patent...

Read more
Canadian Court again rejects problem-solution approach to subject-matter eligibility of computer-implemented patents
Osler Update December 13, 2021

Time to talk about ownership of AI-generated intellectual property assets

Systems for protecting intellectual property (IP) have been in place since the Middle Ages, encouraging skilled, innovative technicians by granting...

Read more
Time to talk about ownership of AI-generated intellectual property assets